226 related articles for article (PubMed ID: 26462052)
1. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.
Kishore Kumar GD; Chavarria GE; Charlton-Sevcik AK; Arispe WM; Macdonough MT; Strecker TE; Chen SE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2010 Feb; 20(4):1415-9. PubMed ID: 20089402
[TBL] [Abstract][Full Text] [Related]
3. Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.
Kumar GD; Chavarria GE; Charlton-Sevcik AK; Yoo GK; Song J; Strecker TE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2010 Nov; 20(22):6610-5. PubMed ID: 20933415
[TBL] [Abstract][Full Text] [Related]
4. Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L.
Chavarria GE; Horsman MR; Arispe WM; Kumar GD; Chen SE; Strecker TE; Parker EN; Chaplin DJ; Pinney KG; Trawick ML
Eur J Med Chem; 2012 Dec; 58():568-72. PubMed ID: 23168380
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks.
Song J; Jones LM; Chavarria GE; Charlton-Sevcik AK; Jantz A; Johansen A; Bayeh L; Soeung V; Snyder LK; Lade SD; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2013 May; 23(9):2801-7. PubMed ID: 23540644
[TBL] [Abstract][Full Text] [Related]
6. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.
Tyagi C; Grover S; Dhanjal J; Goyal S; Goyal M; Grover A
BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S10. PubMed ID: 24564425
[TBL] [Abstract][Full Text] [Related]
8. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
Hu K; Yang ZH; Pan SS; Xu HJ; Ren J
Eur J Med Chem; 2010 Aug; 45(8):3453-8. PubMed ID: 20494492
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L.
Song J; Jones LM; Kumar GD; Conner ES; Bayeh L; Chavarria GE; Charlton-Sevcik AK; Chen SE; Chaplin DJ; Trawick ML; Pinney KG
ACS Med Chem Lett; 2012 Jun; 3(6):450-3. PubMed ID: 24900494
[TBL] [Abstract][Full Text] [Related]
11. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
Torkar A; Lenarčič B; Lah T; Dive V; Devel L
Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
[TBL] [Abstract][Full Text] [Related]
12. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro.
Sever N; Filipic M; Brzin J; Lah TT
Biol Chem; 2002 May; 383(5):839-42. PubMed ID: 12108549
[TBL] [Abstract][Full Text] [Related]
13. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins.
Dana D; Davalos AR; De S; Rathod P; Gamage RK; Huestis J; Afzal N; Zavlanov Y; Paroly SS; Rotenberg SA; Subramaniam G; Mark KJ; Chang EJ; Kumar S
Bioorg Med Chem; 2013 Jun; 21(11):2975-87. PubMed ID: 23623677
[TBL] [Abstract][Full Text] [Related]
14. Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead.
Ettari R; Tamborini L; Angelo IC; Grasso S; Schirmeister T; Lo Presti L; De Micheli C; Pinto A; Conti P
ChemMedChem; 2013 Dec; 8(12):2070-6. PubMed ID: 24243827
[TBL] [Abstract][Full Text] [Related]
15. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
Gopal P; Rehman RU; Chadha KS; Qiu M; Colella R
Oncol Rep; 2006 Aug; 16(2):313-20. PubMed ID: 16820909
[TBL] [Abstract][Full Text] [Related]
16. 3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.
Zhou NE; Guo D; Thomas G; Reddy AV; Kaleta J; Purisima E; Menard R; Micetich RG; Singh R
Bioorg Med Chem Lett; 2003 Jan; 13(1):139-41. PubMed ID: 12467634
[TBL] [Abstract][Full Text] [Related]
17. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B.
Cunha RL; Urano ME; Chagas JR; Almeida PC; Bincoletto C; Tersariol IL; Comasseto JV
Bioorg Med Chem Lett; 2005 Feb; 15(3):755-60. PubMed ID: 15664852
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.
Mullins SR; Sameni M; Blum G; Bogyo M; Sloane BF; Moin K
Biol Chem; 2012 Dec; 393(12):1405-16. PubMed ID: 23667900
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
20. Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
Mendieta L; Picó A; Tarragó T; Teixidó M; Castillo M; Rafecas L; Moyano A; Giralt E
ChemMedChem; 2010 Sep; 5(9):1556-67. PubMed ID: 20652927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
